Safety and effectiveness of nusinersen, a treatment for spinal muscular atrophy, in 524 patients: results from an interim analysis of post-marketing surveillance in Japan

.

Source: International Journal of Neuroscience - September 7, 2023 Category: Neuroscience Authors: Yosuke Tachibana Ryusuke Sato Haruki Makioka Misuzu Hoshino Mingshou Jin Source Type: research